Treat Parkinson's Disease with a Cancer Drug

Links shared publicly online about this topic.

  • 826
    total visits

Treat Parkinson's Disease with a Cancer Drug

hcplive.com

Findings from a recent Johns Hopkins study show that a class of cancer drugs could have a new target in Parkinson's disease.

View full resource at hcplive.com

Tags: Parkinson's Disease, Cancer, Cancer Medication, Disease and Condition, Drug, Johns Hopkins Hospital, disease

  • Share

Most Recently Shared on October 4, 2010 at 7:13 pm By:

HCPLive_Neuro HCPLive

Cancer drug class could find new target in Parkinson's disease -http://hcp.lv/cxi1Wb

2 years ago...

PolygenicBlog: Scientists Reprogram Cancer Cells With Low Doses Of Epigenetic Drugs - News Story - Biocompare Buyer's Guide For Life Scientists

polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigueView full resource at polygenicpathways.blogspot.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 10:20 am By:

ChrisCarter http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter PhD, Doctor, Medical Technology, and Pharmacist

Scientists Reprogram #Cancer Cells With Low Doses Of #Epigenetic Drugs - News Story… http://t.co/40TS02HX

3 weeks ago...

India bats for generic drugs, seeks Africa's support - The Economic Times

economictimes.indiatimes.com — “According to Sharma, Indian generic drugs have significantly brought down the medicine cost for treating major diseases like cancer and AIDS.View full resource at economictimes.indiatimes.com

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 1:52 am By:

HIV_Wisdom OrganizedWisdom HIV OW Health

India bats for generic drugs, seeks Africa's support: According to Sharma, Indian generic drugs have significant... http://t.co/hFEcz2rz

4 weeks ago...

Cancer drug improves memory in mouse model of Alzheimer's disease

eurekalert.org — “A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a study in the March 14 issue of the Journal of Neuroscience. The findings suggest the drug epothilone D may one day prove useful for treating people with early-stage Alzheimer's disease.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 4:10 pm By:

BrainCancer_OW Brain Cancer OW OW Health

Cancer drug improves memory in mouse model of Alzheimer's disease: (Society for Neuroscience) A compound that pr... http://t.co/00DESYZJ

1 month ago...

Alzheimer's Mice Treated With Cancer Drug Show Improved Memory

medicalnewstoday.com — “A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according toView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 10:05 am By:

mnt_alzheimers MNT Alzheimer's News Health News

Alzheimer's Mice Treated With Cancer Drug Show Improved Memory http://t.co/51Ti3dpv #alzheimers

1 month ago...

Skin cancer drug reverses Alzheimer's in mice - CNN.com

cnn.com — “Scientists say they "serendipitously" discovered that a drug used to treat a type of cancer quickly reversed Alzheimer's disease in mice.View full resource at cnn.com

  • View Related
  • Share

Most Recently Shared on February 9, 2012 at 11:09 pm By:

Cancer Drug Erases Alzheimer's in Mice, But What About Men?: A drug typically used to treat skin cancer quickly ... http://t.co/5SmFKj2Y

abcnews.go.com — “Cancer Drug Erases Alzheimer's in Mice, But What About Men?: A drug typically used to treat skin cancer quickly ... http://t.co/5SmFKj2YView full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on February 9, 2012 at 8:24 pm By:

SusanS_Health Susan Scroggins Health Advocate and Active Health Library

Cancer Drug Erases Alzheimer's in Mice, But What About Men?: A drug typically used to treat skin cancer quickly ... http://t.co/5SmFKj2Y

2 months ago...

FDA Approves Pfizer Cancer Drug - WSJ.com

online.wsj.com — “U.S. regulators approved Pfizer's Inlyta drug for treating advanced kidney cancer, the latest of several drugs to be approved for the disease in recent years.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on January 28, 2012 at 12:40 am By:

Analysis: Goal for Alzheimer's drug by 2025 too ambitious? - Yahoo! News

news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - The U.S. government has set a deadline of 2025 for finding an effective way to treat or prevent Alzheimer's disease, an ambitious target considering there is no cure on the horizon and one that sets a firm deadline unlike previous campaigns against cancer or AIDS. A panel of Alzheimer's experts this week has been fleshing out the first comprehensive plan by the U.S. Department of Health and Human Services (HHS) to fight Alzheimer's disease, an effort mandateView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on January 20, 2012 at 4:00 pm By:

Alzheimer_OW OrganizedWisdom AD OW Health

Analysis: Goal for Alzheimer's drug by 2025 too ambitious?: CHICAGO (Reuters) - The U.S. government has set a de... http://t.co/QGCsoai1

3 months ago...

Alzheimer's Disease Drug by 2025: Is This Goal Too Ambitious? - International Business Times

ibtimes.com — “The U.S. government has set a deadline of 2025 for finding an effective way to treat or prevent Alzheimer's disease, an ambitious target considering there is no cure on the horizon and one that sets a firm deadline unlike previous campaigns against cancer or AIDS.View full resource at ibtimes.com

  • View Related
  • Share

Most Recently Shared on January 20, 2012 at 4:00 pm By:

Alzheimer_OW OrganizedWisdom AD OW Health

Alzheimer's Disease Drug by 2025: Is This Goal Too Ambitious?: The U.S. government has set a deadline of 2025 fo... http://t.co/A0ZeI9Ld

3 months ago...

Analysis: Goal for Alzheimer's drug by 2025 too ambitious? - Yahoo! News

news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - The U.S. government has set a deadline of 2025 for finding an effective way to treat or prevent Alzheimer's disease, an ambitious target considering there is no cure on the horizon and one that sets a firm deadline unlike previous campaigns against cancer or AIDS. A panel of Alzheimer's experts this week has been fleshing out the first comprehensive plan by the U.S. Department of Health and Human Services (HHS) to fight Alzheimer's disease, an effort mandateView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on January 19, 2012 at 9:44 pm By:

Alzheimer_OW OrganizedWisdom AD OW Health

Analysis: Goal for Alzheimer's drug by 2025 too ambitious?: CHICAGO (Reuters) - The U.S. government has set a de... http://t.co/A42ZMZXV

3 months ago...

Goal for Alzheimer’s drug by 2025 too ambitious? | Health & Fitness | Life | Calgary Sun

calgarysun.com — “The U.S. government has set a deadline of 2025 for finding an effective way to treat or prevent Alzheimer’s disease, an ambitious target considering there is no cure on the horizon and one that sets a firm deadline unlike previous campaigns against cancer or AIDS.View full resource at calgarysun.com

  • View Related
  • Share

Most Recently Shared on January 19, 2012 at 9:44 pm By:

Alzheimer_OW OrganizedWisdom AD OW Health

Goal for Alzheimer’s drug by 2025 too ambitious?: The U.S. government has set a deadline of 2025 for finding an ... http://t.co/BU6iO8wN

3 months ago...

New hope for diseases of protein folding such as Alzheimer’s, Parkinson’s diseases, ALS, cancer and diabetes

sciencedaily.com — “Two related studies offer new strategies for tackling the challenges of preventing and treating diseases of protein folding, such as Alzheimer's, Parkinson's and Huntington's diseases, ALS, cystic fibrosis, cancer and type 2 diabetes. The research identifies new genes and pathways that prevent protein misfolding and toxic aggregation, keeping cells healthy, and also identifies small molecules with therapeutic potential that restore health to damaged cells, providing new targets for drug developmView full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on January 9, 2012 at 11:40 am By:

GFMelissa Melissa Patient Expert

New hope for protein folding diseases such as Alzheimer’s, Parkinson’s: http://t.co/VuOvO2gv

3 months ago...

RGS9-2 gene plays a role in regulating body weight

news-medical.net — “Abraham Kovoor was studying a brain protein, called RGS9 2, that he had previously related to the involuntary, random and repetitive body movements that are side effects of drugs used to treat Parkinson's disease and schizophrenia.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 5, 2012 at 7:00 am By:

NewsMedical News-Medical.Net Health News

RGS9-2 gene plays a role in regulating body weight: Abraham Kovoor was studying a brain protein, called RGS9 2, ... http://t.co/hkrKbsMN

3 months ago...

Your Milk on Drugs (Part 2) | Organic Connections

organicconnectmag.com — “Dairy products from cows treated with genetically engineered bovine growth hormone (rBGH or rBST) may sharply increase cancer risk and other diseases, especially in children.View full resource at organicconnectmag.com

  • View Related
  • Share

Most Recently Shared on January 1, 2012 at 12:41 pm By:

Avastin use in ovarian cancer may delay disease - Health - CBC News

cbc.ca — “A drug formerly used to treat advanced breast cancer slightly extend the lifespan of women with advanced ovarian cancer, new research suggests.View full resource at cbc.ca

  • View Related
  • Share

Most Recently Shared on December 30, 2011 at 5:56 pm By:

JoannaLynn Joanna Lynn CAM and Nutritionist

Avastin use in ovarian cancer may delay disease http://t.co/DmaM2Q59

4 months ago...

Advertisement